Toll Free: 1-888-928-9744
Toll Free: 1-888-928-9744
Published: Jun, 2014 | Pages:
77 | Publisher: Grand View Research
Industry: Biotechnology | Report Format: Electronic (PDF)
The global market for healthcare nanotechnology is expected to reach USD 196.02 billion by 2020 growing at a CAGR of 12.1%. Increasing susceptibility of patients towards chronic diseases such as cardiovascular, neurological, oncology and respiratory diseases coupled with increasing R&D spending opening new application avenues is expected to drive market growth over the next six years. Other drivers of this market include increasing government and private sector R&D aid and new players entering the market to bridge the gap between supply and demand.
Clinical oncology nanotechnology applications dominated the overall market in 2013, accounting for 35% of total market revenue. Higher efficacy of nanomaterials and the ability of engineered nanoparticles to cross through the blood brain barrier provides platform for groundbreaking innovations through R&D in the field of cancer therapy and serves this market as a high impact rendering driver.
Further key findings from the study suggest:
North America was the largest regional market in 2013, accounting for over 38% of global revenue on account of the extensive investments in research and development of innovative cancer therapies.
Asia Pacific owing to its improving healthcare infrastructure and healthcare R&D spending is expected to grow at the highest CAGR of over 14.0% from 2014 to 2020. Moreover, emerging markets such as China and India hold a large amount of untapped opportunities and are therefore expected to fuel future market growth.
Cardiovascular applications are expected to be the fastest growing segment for this market, owing to the growing global prevalence of cardiovascular diseases.
For the purpose of this study, Grand View Research has segmented the global healthcare nanotechnology market on the basis of fields of application and region:
Healthcare Nanotechnology Application Outlook
Drug delivery Systems
Molecular Diagnostics
Clinical Oncology
Clinical Neurology
Clinical Cardiology
Anti-inflammatory and Anti-infective applications
Healthcare Nanotechnology Regional Outlook
North America
Europe
Asia Pacific
RoW
Table of Contents
Chapter 1. Executive Summary 1.1. Nanotechnology Healthcare - Industry Summary & Critical Success Factors (CSFs) Chapter 2. Nanotechnology Healthcare Industry Outlook 2.1. Market Segmentation 2.2. Market Size and Growth Prospects 2.3. Nanotechnology Healthcare Market Dynamics 2.3.1. Market Driver Analysis 2.3.1.1. Growing incidences of chronic severe diseases 2.3.1.2. Technological innovation in medical application of nanotechnology 2.3.1.3. Growing geriatric population base 2.4. Key Opportunities Prioritized 2.5. Industry Analysis - Porter's 2.6. Nanotechnology Healthcare market PESTEL Analysis, 2013 Chapter 3. Nanotechnology Healthcare Application Outlook 3.1. Drug Delivery System 3.1.1. Global revenue by region, (USD Million), 2012 - 2020 3.2. Molecular Diagnostics 3.2.1. Global revenue by region, (USD Million), 2012 - 2020 3.3. Clinical Oncology 3.3.1. Global revenue by region, (USD Million), 2012 - 2020 3.4. Clinical Neurology 3.4.1. Global revenue by region, (USD Million), 2012 - 2020 3.5. Clinical Cardiology 3.5.1. Global revenue by region, (USD Million), 2012 - 2020 3.6. Anti-Inflammatory and Anti-Infective applications 3.6.1. Global revenue by region, (USD Million), 2012 - 2020 Chapter 4. Nanotechnology Healthcare Regional Outlook 4.1. North America 4.1.1. Market revenue by application, (USD Million), 2012 - 2020 4.2. Europe 4.2.1. Market revenue by application, (USD Million), 2012 - 2020 4.3. Asia Pacific 4.3.1. Market revenue by application, (USD Million), 2012 - 2020 4.4. RoW 4.4.1. Market revenue by application, (USD Million), 2012 - 2020 Chapter 5 Competitive Landscape 5.1 Abbott Laboratories. 5.1.1 Company Overview 5.1.2 Financial Performance 5.1.3 Product Benchmarking 5.1.4 Strategic Initiatives 5.2 CombiMatrix Corporation 5.2.1 Company Overview 5.2.2 Financial Performance 5.2.3 Product Benchmarking 5.2.4 Strategic Initiatives 5.3 Celgene Corporation 5.3.1 Company Overview 5.3.2 Financial Performance 5.3.3 Product Benchmarking 5.3.4 Strategic Initiatives 5.4 Mallinckrodt plc. 5.4.1 Company Overview 5.4.2 Financial Performance 5.4.3 Product Benchmarking 5.4.4 Strategic Initiatives 5.5 GE Healthcare 5.5.1 Company Overview 5.5.2 Financial Performance 5.5.3 Product Benchmarking 5.5.4 Strategic Initiatives 5.6 Johnson & Johnson 5.6.1 Company Overview 5.6.2 Financial Performance 5.6.3 Product Benchmarking 5.6.4 Strategic Initiatives 5.7 Merck & Company Inc. 5.7.1 Company Overview 5.7.2 Financial Performance 5.7.3 Product Benchmarking 5.7.4 Strategic Initiatives 5.8 Nanosphere Inc. 5.8.1 Company Overview 5.8.2 Financial Performance 5.8.3 Product Benchmarking 5.8.4 Strategic Initiatives 5.9 Pfizer Inc. 5.9.1 Company Overview 5.9.2 Financial Performance 5.9.3 Product Benchmarking 5.9.4 Strategic Initiatives 5.10 Sigma-Tau Pharmaseuticals Inc. 5.10.1 Company Overview 5.10.2 Financial Performance 5.10.3 Product Benchmarking 5.10.4 Strategic Initiatives 5.11 Teva Pharmaseuticals Industries Ltd. 5.11.1 Company Overview 5.11.2 Financial Performance 5.11.3 Product Benchmarking 5.11.4 Strategic Initiatives 5.12 UCB SA 5.12.1 Company Overview 5.12.2 Financial Performance 5.12.3 Product Benchmarking 5.12.4 Strategic Initiatives Chapter 6. Methodology and Scope 6.1. Research Methodology 6.2. Research Scope & Assumption 6.3. List of Data Sources List of Tables
Nanotechnology Healthcare - Industry Summary & Critical Success Factors (CSFs) Global Nanotechnology Healthcare market share (USD Million), 2012 - 2020 Global Nanotechnology Healthcare market by region (USD Million), 2012 - 2020 Global Nanotechnology Healthcare market by application (USD Million), 2012 - 2020 Global Drug Delivery Systems revenue by region, (USD Million), 2012 - 2020 Global Molecular Diagnostics revenue by region, (USD Million), 2012 - 2020 Global Clinical Oncology revenue by region, (USD Million), 2012 - 2020 Global Clinical Neurology revenue by region, (USD Million), 2012 - 2020 Global Clinical Cardiology revenue by region, (USD Million), 2012 - 2020 Global Anti-inflammatory and Anti-infective application revenue by region, (USD Million), 2012 - 2020 North America Nanotechnology Healthcare market by application (USD Million), 2012 - 2020 Europe Nanotechnology Healthcare market by application (USD Million), 2012 - 2020 Asia Pacific Nanotechnology Healthcare market by application (USD Million), 2012 - 2020 RoW Nanotechnology Healthcare market by application (USD Million), 2012 - 2020 List of Figures Nanotechnology Healthcare Market Segmentation Global Nanotechnology Healthcare market (USD Million), 2012 - 2020 Nanotechnology Healthcare value chain analysis Nanotechnology Healthcare market dynamics Nanotechnology Healthcare - Company market share analysis, 2013 Key Opportunities Prioritized Industry Analysis - Porter's Nanotechnology Healthcare PESTEL Analysis, 2013 Nanotechnology Healthcare market share by application, 2012 & 2020 Nanotechnology Healthcare market share by region, 2012 & 2020 Global Drug Delivery Systems revenue by region, (USD Million), 2012 - 2020 Global Molecular Diagnostics revenue by region, (USD Million), 2012 - 2020 Global Clinical Oncology revenue by region, (USD Million), 2012 - 2020 Global Clinical Neurology revenue by region, (USD Million), 2012 - 2020 Global Clinical Cardiology revenue by region, (USD Million), 2012 - 2020 Global Anti-inflammatory and Anti-infective application revenue by region, (USD Million), 2012 - 2020 North America Nanotechnology Healthcare market, by application (USD Million), 2012 - 2020 Europe Nanotechnology Healthcare market, by application(USD Million), 2012 - 2020 Asia Pacific Nanotechnology Healthcare market, by application(USD Million), 2012 - 2020 RoW Nanotechnology Healthcare market, by application(USD Million), 2012 - 2020
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.
